These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9404344)

  • 1. [Conn's syndrome. Study of systemic cardiovascular hemodynamics after medical treatment with spironolactone and after surgical treatment].
    Amah G; Blacher J; Girerd X; Kheder A; Ben Maiz H; Safar M
    Presse Med; 1997 Oct; 26(29):1372-7. PubMed ID: 9404344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing pattern of the intraoperative blood pressure during endoscopic adrenalectomy in patients with Conn's syndrome.
    Gockel I; Heintz A; Kentner R; Werner C; Junginger T
    Surg Endosc; 2005 Nov; 19(11):1491-7. PubMed ID: 16222471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined captopril and spironolactone treatment in Conn's syndrome with renal impairment and refractory hypertension.
    Atkinson AB; Brown JJ; Davies DL; Lever AF; Robertson JI
    Clin Endocrinol (Oxf); 1981 Jan; 14(1):105-8. PubMed ID: 7014043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conn's syndrome presenting as depression.
    Khurshid KA; Weaver ME
    Am J Psychiatry; 2005 Jun; 162(6):1226. PubMed ID: 15930081
    [No Abstract]   [Full Text] [Related]  

  • 5. [Conn's syndrome].
    Born-Frontsberg E; Quinkler M
    Internist (Berl); 2009 Jan; 50(1):17-26. PubMed ID: 19099278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Spironolactone in essential hypertension associated with abnormal aldosterone regulation and in Conn's syndrome (author's transl)].
    Wambach G; Helber A; Bönner G; Hummerich W; Meurer KA; Kaufmann W
    Dtsch Med Wochenschr; 1980 May; 105(18):647-51. PubMed ID: 7371530
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of aldosterone and 18-hydroxycorticosterone to angiotensin II in normal subjects and patients with essential hypertension, Conn's syndrome, and nontumorous hyperaldosteronism.
    Fraser R; Beretta-Piccoli C; Brown JJ; Cumming AM; Lever AF; Mason PA; Morton JJ; Robertson JI
    Hypertension; 1981; 3(3 Pt 2):I87-92. PubMed ID: 7262982
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Test and teach. Surgically correctable hypertension. Conn's syndrome and spironolactone bodies.
    Al Saad KO; Chan NH
    Pathology; 2001 Nov; 33(4):508-10. PubMed ID: 11827421
    [No Abstract]   [Full Text] [Related]  

  • 9. [Secondary forms of hypertension. 5. Hypertension caused by Cushing syndrome and Conn's disease].
    Füessl HS
    MMW Fortschr Med; 2002 Feb; 144(9):42-4. PubMed ID: 11921653
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentration of renin in a patient with Conn's syndrome with fibrinoid lesions of the renal arterioles: the effect of treatment with spironolactone.
    Brown JJ; Davies DL; Lever AF; Peart WS; Robertson JI
    J Endocrinol; 1965 Oct; 33(2):279-93. PubMed ID: 5845288
    [No Abstract]   [Full Text] [Related]  

  • 11. Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study.
    Douma S; Petidis K; Doumas M; Papaefthimiou P; Triantafyllou A; Kartali N; Papadopoulos N; Vogiatzis K; Zamboulis C
    Lancet; 2008 Jun; 371(9628):1921-6. PubMed ID: 18539224
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Conn's syndrome with adrenocortical adenoma. Action of spirolactone, SC-9420].
    GADRAT J; DELAUDE A; JORDA MF; MOREAU G
    Bull Mem Soc Med Hop Paris; 1962; 113():541-55. PubMed ID: 13896125
    [No Abstract]   [Full Text] [Related]  

  • 13. [Anesthesia-intensive care in surgery for Conn's syndrome].
    du Gres B; Samuel D; Philippe M; Chassignolle J; Estanove S
    Anesth Analg (Paris); 1978; 35(2):263-7. PubMed ID: 697065
    [No Abstract]   [Full Text] [Related]  

  • 14. Laparoscopic adrenalectomy for Conn's syndrome: report of the initial six cases.
    Mishra AK; Agarwal A; George RK; Gupta S; Mishra SK
    Int Surg; 2009; 94(1):31-4. PubMed ID: 20099423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence of hypertension in primary aldosteronism after discontinuation of spironolactone. Time course of changes in cardiac output and body fluid volumes.
    Wenting GJ; Man in 't Veld AJ; Derkx FH; Schalekamp MA
    Clin Exp Hypertens A; 1982; 4(9-10):1727-48. PubMed ID: 6754151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diagnosis and therapy of primary hyperaldosteronism in general practice].
    Bellin H; Naumann G; Schultz J
    Z Gesamte Inn Med; 1975 Jun; 30(11):391-6. PubMed ID: 1199253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Body elemental composition, with particular reference to total and exchangeable sodium and potassium and total chlorine, in untreated and treated primary hyperaldosteronism.
    Williams ED; Boddy K; Brown JJ; Cumming AM; Davies DL; Harvey IR; Haywood JK; Lever AF; Robertson JI
    J Hypertens; 1984 Apr; 2(2):171-6. PubMed ID: 6533185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Crohn's disease and Conn's syndrome. A report of two cases.
    Astegiano M; Bresso F; Demarchi B; Sapone N; Novero D; Palestro G; Resegotti A; Pellicano R; Rizzetto M
    Panminerva Med; 2005 Mar; 47(1):61-4. PubMed ID: 15985978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spontaneous remission of idiopathic aldosteronism after long-term treatment with spironolactone: results from the German Conn's Registry.
    Fischer E; Beuschlein F; Degenhart C; Jung P; Bidlingmaier M; Reincke M
    Clin Endocrinol (Oxf); 2012 Apr; 76(4):473-7. PubMed ID: 21958049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conn's syndrome: a simple diagnostic approach.
    Mathew S; Perakath B; Nair A; Rajaratnam S; Seshadri MS
    Natl Med J India; 1999; 12(5):214-6. PubMed ID: 10613001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.